Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation

[1]  C. Rozman,et al.  Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia , 1996, Annals of Internal Medicine.

[2]  J. Sierra,et al.  Marrow transplants from unrelated donors. , 1995, Clinical transplants.

[3]  J. Hansen,et al.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.

[4]  D. Siegel,et al.  Biology and treatment of multiple myeloma. , 1993, Blood reviews.

[5]  J. Ferrara,et al.  Cytokine dysregulation and acute graft-versus-host disease. , 1992, Blood.

[6]  J. Kersey,et al.  RISK FACTORS FOR ACUTE GRAFT‐VERSUS‐HOST DISEASE IN HISTOCOMPATIBLE DONOR BONE MARROW TRANSPLANTATION , 1991, Transplantation.

[7]  A. Gratwohl,et al.  Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG. , 1991, Bone marrow transplantation.

[8]  R. Storb.  Graft rejection and graft-versus-host disease in marrow transplantation. , 1989, Transplantation proceedings.

[9]  J. Sprent,et al.  T cell subsets and graft-versus-host disease. , 1987, Transplantation.

[10]  A. Gallamini,et al.  Allogeneic bone marrow transplantation in multiple myeloma. , 1987, Acta haematologica.

[11]  B. Dupont,et al.  Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. , 1986, Blood.

[12]  H. Deeg,et al.  Bone marrow transplantation in patients aged 45 years and older. , 1986, Blood.

[13]  D. Uphoff.  Comparative survival of lethally irradiated inbred male mice inoculated with marrow from virgin or multiparous female donors. , 1975, Journal of the National Cancer Institute.